Assessment of the Immunogenicity and Safety of PENTAXIM in Philippines.

Trial Profile

Assessment of the Immunogenicity and Safety of PENTAXIM in Philippines.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2013

At a glance

  • Drugs Hib-DTaP-poliovirus vaccine (Primary) ; Hepatitis B vaccine recombinant
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 22 Apr 2008 Status changed from in progress to completed, according to clinicaltrials.gov.
    • 17 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top